Skip to content

Safety evaluation of excessive intake of food containing lactic acid bacteria

Safety evaluation of excessive intake of food containing lactic acid bacteria - Safety evaluation of excessive intake of food containing lactic acid bacteria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044729
Enrollment
10
Registered
2021-07-01
Start date
2021-07-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of test food for 4 consecutive weeks

Sponsors

EP Mediate Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy males and females from 20 to 64 years old

Exclusion criteria

Exclusion criteria: (1) Subjects who are judged as unsuitable for the study based on the results of the lifestyle questionnaire (2) Subjects who have serious disease or history of those illnesses (e.g., diabetes, liver disease, kidney disease, heart disease, respiratory disease, endocrine diseases, or metabolic disease) (3) Subjects who are judged as unsuitable for the study based on the results of clinical examination or cardiopulmonary abnormality (4) Subjects having possibilities for emerging allergy related to the study (5) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (6) Subjects who have participated in other clinical studies (7) Subjects who intend to become pregnant or lactating during the test period (8) Subjects judged as unsuitable for the study by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Hematologic test Blood biochemistry test Urine analysis Blood pressure/pulsation Body weight/body mass index Doctor's question Adverse event

Countries

Japan

Contacts

Public ContactNahomi Noji

EP Mediate Co., Ltd. Development Business Headquarters, TTC Center, Trial Planning Department

noji590@eps.co.jp03-5657-4983

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026